Joanna Kaźmierska1. 1. Radiotherapy Department II, Greater Poland Cancer Center, Poznan, Poland ; Electroradiology Department, University of Medical Sciences, Poznan, Poland.
Abstract
BACKGROUND: Mycosis fungoides (MF) is a rare skin condition, effectively treated by irradiation. Since 1951, different methods of total skin irradiation have been developed. Although dose-response effect has been demonstrated in many publications, controversies about low dose treatment still exist. AIM: The analysis of results of the total skin electron irradiation (TSEI), especially low dose TSEI in comparison with standard dose treatment is the subject of this review. Also, acute and late side effects of radiotherapy in MF are discussed. MATERIALS AND METHODS: Medline search and analysis of studies published between 1995 and 2012, containing key words: mycosis fungoides, standard dose TSEI, low dose TSEI, total skin electron beam therapy (TSEBT). RESULTS: Detailed analysis of relevant studies demonstrated that standard dose radiotherapy 30-36 Gy is the most effective treatment used in clinical practice. Objective response rate (ORR) is high, especially for less advanced stages of disease. Complete response rate (CR), although slightly lower, is still relatively high. For more advanced MF, TSEI serves as a very good method of palliative treatment and relief of symptoms, like pruritus, pain or desquamation. There is no consensus regarding low dose TSEI; the method is widely accepted as a palliative treatment or in case of reirradiation. CONCLUSIONS: Standard dose TSEI is an effective method of MF treatment for radical and palliative treatment, producing high rate of ORR and reasonably long time to progression (TTP). Acute and late side effect of treatment are mostly mild and easy to manage. Low dose TSEI is still in the phase of clinical studies.
BACKGROUND:Mycosis fungoides (MF) is a rare skin condition, effectively treated by irradiation. Since 1951, different methods of total skin irradiation have been developed. Although dose-response effect has been demonstrated in many publications, controversies about low dose treatment still exist. AIM: The analysis of results of the total skin electron irradiation (TSEI), especially low dose TSEI in comparison with standard dose treatment is the subject of this review. Also, acute and late side effects of radiotherapy in MF are discussed. MATERIALS AND METHODS: Medline search and analysis of studies published between 1995 and 2012, containing key words: mycosis fungoides, standard dose TSEI, low dose TSEI, total skin electron beam therapy (TSEBT). RESULTS: Detailed analysis of relevant studies demonstrated that standard dose radiotherapy 30-36 Gy is the most effective treatment used in clinical practice. Objective response rate (ORR) is high, especially for less advanced stages of disease. Complete response rate (CR), although slightly lower, is still relatively high. For more advanced MF, TSEI serves as a very good method of palliative treatment and relief of symptoms, like pruritus, pain or desquamation. There is no consensus regarding low dose TSEI; the method is widely accepted as a palliative treatment or in case of reirradiation. CONCLUSIONS: Standard dose TSEI is an effective method of MF treatment for radical and palliative treatment, producing high rate of ORR and reasonably long time to progression (TTP). Acute and late side effect of treatment are mostly mild and easy to manage. Low dose TSEI is still in the phase of clinical studies.
Entities:
Keywords:
Low dose TSEI; Mycosis fungoides; Standard dose TSEI; Total skin electron beam therapy (TSEBT)
Authors: P A Quirós; G W Jones; B M Kacinski; I M Braverman; P W Heald; R L Edelson; L D Wilson Journal: Int J Radiat Oncol Biol Phys Date: 1997-07-15 Impact factor: 7.038
Authors: Lise M Lindahl; Maria R Kamstrup; Peter M Petersen; Johan Wirén; Morten Fenger-Grøn; Robert Gniadecki; Lars Iversen; Lena Specht Journal: Acta Oncol Date: 2011-07-08 Impact factor: 4.089
Authors: P Maingon; G Truc; S Dalac; I Barillot; D Lambert; T Petrella; S Naudy; J C Horiot Journal: Radiother Oncol Date: 2000-01 Impact factor: 6.280
Authors: Maria R Kamstrup; Lena Specht; Gunhild L Skovgaard; Robert Gniadecki Journal: Int J Radiat Oncol Biol Phys Date: 2008-01-22 Impact factor: 7.038
Authors: M Kinoshita-Ise; T Ouchi; E Izumi; O Kawaguchi; K Nagao; M Amagai; T Funakoshi Journal: Clin Exp Dermatol Date: 2017-12-21 Impact factor: 3.470